Syra Health Corp - Class A Common Stock

NEW
NAS:SYRA (USA)   Class A Common Stock
$ 0.33 +0.0089 (+2.76%) 07:08 PM EST
At Loss
P/B:
1.14
Market Cap:
$ 3.94M
Enterprise V:
$ 1.89M
Volume:
228.15K
Avg Vol (2M):
975.53K
Warning! GuruFocus detected 4 Severe warning signs with SYRA. Try a 7-Day Free Trial to check it out.
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
228.15K
Market Cap $:
3.94M
At Loss
Avg Vol (2M):
975.53K
Enterprise Value $:
1.89M
PB Ratio:
1.14
Website SEC Filings Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Syra Health Corp
NAICS : 621112 SIC : 7361
ISIN : US87168W2035
https://www.syrahealth.com
1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Share Class Description:

SYRA: Class A Common Stock
Compare
Compare
ATIPBICXNIVFGBCSGRSTJRSSRHEPBACKVLXCNVOSHCASAU:4013XTER:FRESZSE:300015XKLS:5225XTER:FMETHCUHSBSP:RDOR3DVA
Traded in other countries / regions
SYRA.USA
IPO Date
2023-09-29
Description
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Financial Strength

7/10
Name Current Vs Industry Vs History
Cash-To-Debt 5.3
Equity-to-Asset 0.78
Debt-to-Equity 0.16
Debt-to-EBITDA -0.12
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.74
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 76
3-Year FCF Growth Rate -210.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 25.52
9-Day RSI 30.17
14-Day RSI 35.14
3-1 Month Momentum % 2.31
6-1 Month Momentum % -10
12-1 Month Momentum % -76.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.46
Quick Ratio 5.46
Cash Ratio 3.9
Days Sales Outstanding 38.06
Days Payable 22.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.4
Shareholder Yield % -37.36

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % 20.7
Operating Margin % -47.17
Net Margin % -47.09
FCF Margin % -36.87
ROE % -119.23
ROA % -90.29
ROIC % -422.37
3-Year ROIIC % -508.38
ROC (Joel Greenblatt) % -493.28
ROCE % -114.06

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.32
PB Ratio 1.14
Price-to-Tangible-Book 1.14
EV-to-EBIT -0.51
EV-to-EBITDA -0.51
EV-to-Revenue 0.24
EV-to-Forward-Revenue 0.86
EV-to-FCF -0.65
Price-to-Net-Current-Asset-Value 1.27
Price-to-Net-Cash 2.07
Earnings Yield (Greenblatt) % -196.08
FCF Yield % -74.68

Financials

SYRA's 30-Y Financials
AAPL
Income Statement Breakdown FY
Not Enough Data
AAPL
Balance Sheet Breakdown
Not Enough Data
AAPL
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SYRA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Syra Health Corp Executives

Details

GF Value

SYRA

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.982
EPS (TTM) ($) -0.51
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 83.26
14-Day RSI 35.14
14-Day ATR ($) 0.037293
20-Day SMA ($) 0.36477
12-1 Month Momentum % -76.86
52-Week Range ($) 0.3138 - 2.27
Shares Outstanding (Mil) 11.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Syra Health Corp Filings

Filing Date Document Date Form
No Filing Data

Syra Health Corp Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Syra Health Corp Frequently Asked Questions

What is Syra Health Corp(SYRA)'s stock price today?
The current price of SYRA is $0.33. The 52 week high of SYRA is $2.27 and 52 week low is $0.31.
When is next earnings date of Syra Health Corp(SYRA)?
The next earnings date of Syra Health Corp(SYRA) is .
Does Syra Health Corp(SYRA) pay dividends? If so, how much?
Syra Health Corp(SYRA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.